Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Horst A von Recum

Showing results (1-10 of 73) with videos related to

Pageof 8
Sort By:
Experimental Biology and Medicine (Maywood, N.J.)|March 27, 2019
Microbiome: Our opponents or allies in healthcare and medicineHorst A von Recum
Experimental Biology and Medicine (Maywood, N.J.)|May 19, 2016
From Biocompatibility to Immune EngineeringHorst A von Recum
Tissue Engineering. Part A|October 23, 2009
Endothelial progenitor populations in differentiating embryonic stem cells. II. Drug selection and functional characterizationSaejeong Kim, Horst A von Recum
Tissue Engineering. Part A|June 12, 2009
Endothelial progenitor populations in differentiating embryonic stem cells I: Identification and differentiation kineticsSaejeong Kim, Horst A von Recum
Macromolecular Bioscience|November 26, 2010
Affinity-based drug deliveryNick X Wang, Horst A von Recum
Experimental Biology and Medicine (Maywood, N.J.)|July 13, 2018
Localized and targeted delivery of NSAIDs for treatment of inflammation: A reviewRebecca M Haley, Horst A von Recum
Experimental Biology and Medicine (Maywood, N.J.)|July 17, 2013
Peptide and protein-based inhibitors of HIV-1 co-receptorsHorst A von Recum, Jonathan K Pokorski
Biomaterials|February 19, 2008
Electrospinning: applications in drug delivery and tissue engineeringTravis J Sill, Horst A von Recum
Molecular Pharmaceutics|January 28, 2017
Using Affinity To Provide Long-Term Delivery of Antiangiogenic Drugs in Cancer TherapyEdgardo Rivera-Delgado, Horst A von Recum
Experimental Biology and Medicine (Maywood, N.J.)|January 24, 2017
Emerging technologies for long-term antimicrobial device coatings: advantages and limitationsErika L Cyphert, Horst A von Recum
Pageof 8

Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
Experimental Biology and Medicine (Maywood, N.J.)|March 27, 2019
Microbiome: Our opponents or allies in healthcare and medicineHorst A von Recum
Experimental Biology and Medicine (Maywood, N.J.)|May 19, 2016
From Biocompatibility to Immune EngineeringHorst A von Recum
Tissue Engineering. Part A|October 23, 2009
Endothelial progenitor populations in differentiating embryonic stem cells. II. Drug selection and functional characterizationSaejeong Kim, Horst A von Recum
Tissue Engineering. Part A|June 12, 2009
Endothelial progenitor populations in differentiating embryonic stem cells I: Identification and differentiation kineticsSaejeong Kim, Horst A von Recum
Macromolecular Bioscience|November 26, 2010
Affinity-based drug deliveryNick X Wang, Horst A von Recum
Experimental Biology and Medicine (Maywood, N.J.)|July 13, 2018
Localized and targeted delivery of NSAIDs for treatment of inflammation: A reviewRebecca M Haley, Horst A von Recum
Experimental Biology and Medicine (Maywood, N.J.)|July 17, 2013
Peptide and protein-based inhibitors of HIV-1 co-receptorsHorst A von Recum, Jonathan K Pokorski
Biomaterials|February 19, 2008
Electrospinning: applications in drug delivery and tissue engineeringTravis J Sill, Horst A von Recum
Molecular Pharmaceutics|January 28, 2017
Using Affinity To Provide Long-Term Delivery of Antiangiogenic Drugs in Cancer TherapyEdgardo Rivera-Delgado, Horst A von Recum
Experimental Biology and Medicine (Maywood, N.J.)|January 24, 2017
Emerging technologies for long-term antimicrobial device coatings: advantages and limitationsErika L Cyphert, Horst A von Recum
Pageof 8